CLPT
Clearpoint Neuro Inc
14.00$
+1.0%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 87.5% | 84.4% | 82.2% | 91.7% | 84.7% | 87.1% | 86.3% | 94.4% | 92.2% | 84.8% | 85.1% | 65.1% | |
| 69.1% | 53.5% | 44.8% | 66.8% | 39.5% | 47.8% | 68.1% | 82.5% | 49.8% | 54.2% | 51.3% | 47.0% | |
| 69.1% | 53.5% | 44.8% | 66.8% | 39.5% | 47.8% | 68.1% | 82.5% | 67.6% | 54.2% | 51.3% | 47.0% | |
| 3.5% | 12.1% | 11.7% | 6.8% | 15.7% | 9.1% | 6.4% | 3.6% | 4.8% | 9.2% | 12.0% | 7.4% | |
| 14.7% | 17.9% | 23.9% | 16.7% | 26.8% | 27.2% | 11.0% | 7.5% | 16.8% | 18.5% | 17.5% | 8.6% | |
| – | 4.4% | 4.4% | 1.9% | 4.8% | 6.9% | 10.3% | 4.2% | 2.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 0.0% | 7.6% | |
| – | – | – | – | – | – | 1.2% | 0.4% | 1.9% | 2.4% | 1.2% | 14.2% | |
| 100.7% | 119.6% | 110.2% | 58.1% | 80.8% | 61.5% | 91.9% | 25.6% | 33.5% | 50.4% | 35.2% | 71.3% | |
| 36.8% | 75.8% | 40.8% | 31.6% | 25.6% | 32.1% | 10.8% | 7.2% | 12.2% | 17.4% | 26.4% | 11.0% | |
| – | 41.8% | 15.1% | 14.4% | – | 1.0% | 1.3% | 0.8% | 1.0% | 1.0% | 1.4% | 0.7% | |
| 7.4% | 6.9% | 20.9% | 5.5% | 6.4% | 8.1% | 1.0% | 0.7% | 0.5% | 0.9% | 3.4% | 1.3% | |
| – | 36.8% | 60.7% | 21.0% | 44.3% | 17.4% | 72.1% | 15.0% | 17.8% | 23.3% | – | 50.2% | |
| -0.7% | -19.6% | -10.2% | 41.9% | 19.2% | 38.5% | 8.1% | 74.4% | 66.5% | 49.6% | 64.8% | 28.7% | |
| -577.3% | -848.5% | -1,268.3% | -727.0% | -1,364.4% | -945.3% | -404.9% | -204.2% | -271.0% | -404.2% | -488.3% | -221.9% | |
| 11.1% | 18.7% | 37.2% | 55.7% | 139.1% | 110.3% | 53.7% | 31.6% | 43.6% | 57.7% | 69.0% | 29.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.